Delivery Order SPE2DB20D1100-SPE2DB25FA3U7

Award Date 1/31/25
Potential Completion Date 2/3/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award with ID SPE2DB20D1050|SPE2DB25FH45P was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,116.21 firm fixed-price contract is a delivery order that provides the DLA with Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract has an ultimate completion date of January 21, 2025 and was awarded on January 17, 2025. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,098.90 firm-fixed-price delivery order contract is for the supply of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,089.60 firm fixed-price delivery order is for the provision of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,022.43 firm fixed-price delivery order is for the supply of 4566691440 FLUTICASONE PROP HFA 44 MCG 10.6GM, a pharmaceutical product. The contract has an ultimate completion date of December 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,571.49 for the supply of Fluticasone Prop HFA 110 MCG 12GM. The award was made by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of August 9, 2024. The contract is a Firm Fixed Price arrangement. Amerisourcebergen is supplying this pharmaceutical product as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,124.90 firm fixed-price delivery order is for the procurement of FLUTICASONE PROP HFA 44 MCG 10.6GM, a pharmaceutical product. The contract has an ultimate completion date of February 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,173.59 firm-fixed-price delivery order is for the supply of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. The contract has an ultimate completion date of November 6, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $51,383.80 firm fixed-price delivery order is for the supply of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. The contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award with ID SPE2DB22D3401|SPE2DB25FT0WU was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,747.21 firm fixed-price delivery order is for the supply of FLUTICASONE PROP HFA 44 MCG 10.6GM medical products, with a completion date of November 25, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, provides delivery of Fluticasone Prop HFA 110 MCG 12GM to support federal government medical requirements. The $1,785.36 firm fixed price contract is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 17, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA3U7
    Delivery Order

This federal contract award SPE2DB20D1100|SPE2DB25FA3U7 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,400.52 firm fixed-price delivery order is for the supply of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract has an ultimate completion date of February 3, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract was not designated with any specific set-aside requirements, indicating open competition.

Generated 5/4/25, 1:06 AM